Pharmaceutical companies and precision medicine companies could also use the data to develop new drugs. It wouldn’t be the ...

Overall, the vision, as outlined in a memo, is to downsize by consolidating some work inside its headquarters, while farming ...

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...

Novo Nordisk on Monday announced a $2 billion deal with a Chinese company making a drug in the same GLP-1 space where the ...

A law passed in 2011 required food companies to track food in the event of contamination and a recall. The administration ...

If left unchecked, the power of PBMs and their complex relationships within the American healthcare system could lead to higher drug costs and diminished returns.

The race is under way to make faster, cheaper and better GLP-1 drugs that will go beyond reducing obesity levels to treating ...

The 10 most innovative biotech companies of 2025 are leveraging AI to find new drugs, match patients with the best treatments, and even support biodiversity research. This year’s list of biotech ...

Lexicon's stock rose 60% after securing a potential $1 billion deal with Novo Nordisk for preclinical obesity drug LX9851.

As more people lose weight using medications like Ozempic, Wegovy and Mounjaro, food companies ramp up their efforts to keep ...

Whether finding new treatments for schizophrenia or first-time ways to tackle bladder cancer, these companies are finding forward-looking therapies. In 2024, drugmakers delivered breakthrough ...

Eli Lilly launches diabetes and obesity drug Mounjaro in India, offering innovative treatment for metabolic health management ...